ES2117950B1 - Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular. - Google Patents

Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular.

Info

Publication number
ES2117950B1
ES2117950B1 ES9601893A ES9601893A ES2117950B1 ES 2117950 B1 ES2117950 B1 ES 2117950B1 ES 9601893 A ES9601893 A ES 9601893A ES 9601893 A ES9601893 A ES 9601893A ES 2117950 B1 ES2117950 B1 ES 2117950B1
Authority
ES
Spain
Prior art keywords
compounds
phosphorylcholine
biosynthesis
messenger
block
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9601893A
Other languages
English (en)
Other versions
ES2117950A1 (es
Inventor
Ubeda Antonio Espinosa
Sanjuan Juan Carlos Lacal
Mezo Miguel Angel Gallo
Rosa Joaquin Maria Campos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Granada
Original Assignee
Universidad de Granada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Granada filed Critical Universidad de Granada
Priority to ES9601893A priority Critical patent/ES2117950B1/es
Priority to PCT/ES1997/000205 priority patent/WO1998005644A1/es
Publication of ES2117950A1 publication Critical patent/ES2117950A1/es
Application granted granted Critical
Publication of ES2117950B1 publication Critical patent/ES2117950B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION ESTA RELACIONADA CON EL DISEÑO, SINTESIS Y ACTIVIDAD BIOLOGICA DE DOS NUEVAS ESTRATEGIAS PARA ABORDAR EL DESARROLLO DE COMPUESTOS QUE PRESENTEN ACTIVIDADES SELECTIVAS COMO ANTICANCEROSOS, ANTIVIRALES, ANTIPARASITARIOS Y ANTIFUNGICOS. AQUI SE DESCRIBE LA UTILIZACION DE LA INHIBICION DE LA BIOSINTESIS DE FOSFORILCOLINA Y DE SU ACCION MITOGENICA COMO UNA NUEVA ESTRATEGIA PARA EL TRATAMIENTO DE TUMORES Y DE ENFERMEDADES PARASITARIAS O PRODUCIDAS POR VIRUS Y HONGOS EN ANIMALES Y EN HUMANOS. LOS COMPUESTOS QUE SE DESCRIBEN PERTENECEN A LAS FAMILIAS ESTRUCTURALES QUE HAN DEMOSTRADO ACTIVIDAD ANTITUMORAL, ANTIPARASITARIA Y ANTIFUNGICA, QUE DEBEN SER CONSIDERADOS Y PROTEGIDOS COMO COMPUESTOS DIRECTAMENTE UTILIZADOS EN EL TRATAMIENTO DE ESTAS ENFERMEDADES EN ANIMALES Y HUMANOS. FINALMENTE, SE DESCRIBEN Y PROTEGEN TAMBIEN LOS METODOS SINTETICOS DE TODOS LOS COMPUESTOS DESCRITOS.
ES9601893A 1996-08-02 1996-08-02 Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular. Expired - Fee Related ES2117950B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES9601893A ES2117950B1 (es) 1996-08-02 1996-08-02 Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular.
PCT/ES1997/000205 WO1998005644A1 (es) 1996-08-02 1997-08-01 Nuevos compuestos con actividad selectiva antitumoral, antiviral, antiparasitaria y antifungica que bloquean la biosintesis de fosforilcolina mediante inhibicion selectiva de colina quinasa intracelular o su utilizacion como segundo mensajero en proliferacion celular

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9601893A ES2117950B1 (es) 1996-08-02 1996-08-02 Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular.

Publications (2)

Publication Number Publication Date
ES2117950A1 ES2117950A1 (es) 1998-08-16
ES2117950B1 true ES2117950B1 (es) 1999-09-16

Family

ID=8295957

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9601893A Expired - Fee Related ES2117950B1 (es) 1996-08-02 1996-08-02 Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular.

Country Status (2)

Country Link
ES (1) ES2117950B1 (es)
WO (1) WO1998005644A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2264037A1 (en) * 1996-09-13 1998-03-19 Merck & Co., Inc. Thrombin inhibitors
ES2148092B1 (es) * 1998-08-28 2001-04-16 Consejo Superior Investigacion Sistema de identificacion ("screening") de compuestos con actividad antitumoral, antiviral, antiparasitaria y antifungica.
AU5518899A (en) * 1998-08-28 2000-03-21 Consejo Superior De Investigaciones Cientificas System for screening compounds with antitumoral, antiviral, antiparasitic and antifungal activity
JP4659183B2 (ja) * 2000-07-21 2011-03-30 富士フイルム株式会社 脂肪族置換アミノピリジニウム誘導体
ES2237332B1 (es) * 2004-01-14 2006-11-01 Consejo Sup. Investig. Cientificas Derivados de piridinio y quinolinio.
US8586613B2 (en) 2004-01-14 2013-11-19 Universidad De Granada Pyridinium and quinolinium derivatives
ES2277568B1 (es) 2005-12-30 2008-04-01 Consejo Superior De Investigaciones Cientificas Derivados de triterpenoquinona y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
US20100068302A1 (en) * 2008-09-17 2010-03-18 Traslational Cancer Drugs Pharma, S.L. Methods and compositions for the treatment of cancer
US20110212994A1 (en) 2009-06-26 2011-09-01 Brian Clem Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders
WO2013043961A1 (en) * 2011-09-22 2013-03-28 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of choline kinase
CN102516164B (zh) * 2011-12-09 2013-09-04 中国科学院成都生物研究所 1,2-二芳基-5-取代吡啶盐化合物及其制备方法和用途
WO2015123130A1 (en) * 2014-02-11 2015-08-20 Trustees Of Dartmouth College Type 4 prepilin peptidase inhibitors and methods of use
EP3669872A4 (en) * 2017-08-18 2021-05-05 Shanghai Ennovabio Pharmaceuticals Co., Ltd. FORMYL PYRIDINE DERIVATIVE WITH PD-L1 INHIBITORING EFFECT, MANUFACTURING METHOD FOR IT AND USE THEREOF

Also Published As

Publication number Publication date
ES2117950A1 (es) 1998-08-16
WO1998005644A1 (es) 1998-02-12

Similar Documents

Publication Publication Date Title
ES2117950B1 (es) Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular.
BR0107943A (pt) Sìtios de entrada de ribossoma internos sintéticos e métodos de identificar os mesmos
CL2004001072A1 (es) Compuestos derivados de trifluorofenil-triazolopirimidina; procedimiento de preparacion de los compuestos; compuestos intermediarios utiles como fungicidas.
ES2190803T3 (es) Iminas ciclicas como pesticidas.
ES2181725T3 (es) Inhibidores de hiv proteasa.
PT942904E (pt) Derivados de 3-tiocarbamoilpirazol como pesticidas
ES2146774T3 (es) Polimeros de ioneno que contienen aniones biologicamente activos.
MX168494B (es) Nuevos derivados de pirazolina su preparacion y su uso como plaguisidas
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
PA8550101A1 (es) Derivados de benzamida tiazol y composiciones farmacéuticas para inhibir la proliferación de células, y métodos para su utilización
UY24553A1 (es) Compuestos insecticidas de tipo 5- amino -4-etilsulfinil-pirazol
UA26097A1 (uk) Триазиhові похідhі, що мають гербіцидhу активhість, спосіб їх одержаhhя та гербіцидhа композиція hа їх осhові
ES2059841T3 (es) Nitro compuestos con actividad insecticida.
BR9809516A (pt) Proteìnas com atividades inseticidas e método de uso
ATE275956T1 (de) Veränderung der dns methyltransferase durch kombinationstherapie
CO5221025A1 (es) 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contienen y su uso como agente para la lucha contra organismos daninos
CO4940430A1 (es) Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales
BR0016162A (pt) Composições e métodos para l-nucleosìdeos, lnucleotìdeos e seus análogos
PT1153015E (pt) Pirimidina-2,4,6-trionas uteis como inibidores de metaloproteinases matriciais
TR200400184T2 (tr) Herbisidal bileşiklere tolerans veren DNA molekülleri
BR9910949A (pt) Métodos e composições protetores e curativos para biocontrole de deterioração pós-colheita das plantas
ES2193424T3 (es) Aminas triciclicas farmaceuticamente activas.
BR0009194A (pt) Composição do resorcinol
GT199900078A (es) 2-aminopiridinas que contienen sustituyentes de anillos condensados.
ES2157419T3 (es) Arilazadioxacicloalquenos substituidos, fungicidas.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19980816

Kind code of ref document: A1

Effective date: 19980816

FD2A Announcement of lapse in spain

Effective date: 20161125